A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Factorial Design Clinical Trial to Study the Efficacy and Safety of MK-0462 / Rizatriptan 10 mg for the Early Treatment of Acute Migraine

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

To evaluate the efficacy of rizatriptan ODT/oral lyophilisate compared to placebo in the early treatment (while headache is mild) of acute migraine, as measured by pain freedom at 2 hours post-dose

Critère d'inclusion

Treatment of Acute Migraine when pain severity is mild

Liens

ictrp
euctr